Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2026-01-01 @ 1:02 PM
Study NCT ID:
NCT01234766
Status:
COMPLETED
Last Update Posted:
2021-05-18
First Post:
2010-10-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2010-10-06
First Submit QC Date:
None
Study First Post Date:
2010-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-13
Results First Submit QC Date:
None
Results First Post Date:
2018-05-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-27
Last Update Post Date:
2021-05-18
Last Update Post Date Type:
ACTUAL